Sadowski, M.* ; Thompson, M.* ; Mefford, J.* ; Haldar, T.* ; Oni-Orisan, A.* ; Border, R.* ; Pazokitoroudi, A.* ; Cai, N. ; Ayroles, J.F.* ; Sankararaman, S.* ; Dahl, A.W.* ; Zaitlen, N.*
Characterizing the genetic architecture of drug response using gene-context interaction methods.
Cell Genom. 4:100722 (2024)
Identifying factors that affect treatment response is a central objective of clinical research, yet the role of common genetic variation remains largely unknown. Here, we develop a framework to study the genetic architecture of response to commonly prescribed drugs in large biobanks. We quantify treatment response heritability for statins, metformin, warfarin, and methotrexate in the UK Biobank. We find that genetic variation modifies the primary effect of statins on LDL cholesterol (9% heritable) as well as their side effects on hemoglobin A1c and blood glucose (10% and 11% heritable, respectively). We identify dozens of genes that modify drug response, which we replicate in a retrospective pharmacogenomic study. Finally, we find that polygenic score (PGS) accuracy varies up to 2-fold depending on treatment status, showing that standard PGSs are likely to underperform in clinical contexts.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Gene-environment Interactions ; Genetic Heterogeneity ; Genetic Testing ; Heritability ; Heteroskedasticity ; Personalized Medicine ; Pharmacogenomics; Genome-wide Association; Environment Interactions; Cardiovascular-disease; Polygenic-score; Uk Biobank; Metformin; Therapy; Risk; Efficacy; Genotype
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
2666-979X
e-ISSN
2666-979X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 4,
Issue: 12,
Pages: ,
Article Number: 100722
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Radarweg 29, 1043 Nx Amsterdam, Netherlands
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Helmholtz Pioneer Campus (HPC)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Pioneer Campus
PSP Element(s)
G-510007-001
Grants
National Institutes of Health
Chan Zuckerberg Initiative grant
Copyright
Erfassungsdatum
2024-12-10